|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.002300 USD | +15.00% |
|
-4.17% | -55.77% |
| 05-20 | CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 03-31 | CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Company Valuation: CannaPharmaRX, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 21.89 | 1.584 | 2.569 | 0.7355 | 5.316 | 3.413 |
| Change | - | -92.76% | 62.24% | -71.38% | 622.75% | -35.8% |
| Enterprise Value (EV) 1 | 31.55 | 10.58 | 17.09 | 13.67 | 19.37 | 24.06 |
| Change | - | -66.49% | 61.63% | -20.02% | 41.72% | 24.19% |
| P/E | -1x | -0.11x | -0.25x | 0.17x | -0.51x | -0.31x |
| PBR | -2.46x | -0.12x | -0.14x | -0.05x | -0.26x | -0.11x |
| PEG | - | 0x | 0x | -0x | 0x | -0.05x |
| Capitalization / Revenue | - | - | - | - | 6,481,590x | 2,505,285x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -7x | -4.05x | -3.48x | -9.45x | -5.57x | - |
| EV / EBIT | -6.8x | -4.04x | -3.28x | -8.68x | -5.37x | -7.19x |
| EV / FCF | 4.46x | -2.55x | 44.6x | -10.6x | 9.09x | -6.04x |
| FCF Yield | 22.4% | -39.2% | 2.24% | -9.43% | 11% | -16.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.4887 | -0.1183 | -0.0404 | 0.009999 | -0.0158 | -0.0168 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | 0.8201 | 1.362 |
| EBITDA 1 | -4.51 | -2.614 | -4.917 | -1.447 | -3.477 | - |
| EBIT 1 | -4.638 | -2.616 | -5.212 | -1.575 | -3.605 | -3.348 |
| Net income 1 | -19.89 | -8.832 | -8.531 | 3.688 | -9.906 | -11.13 |
| Net Debt 1 | 9.666 | 8.991 | 14.52 | 12.93 | 14.06 | 20.65 |
| Reference price 2 | 0.490000 | 0.012950 | 0.010000 | 0.001700 | 0.008100 | 0.005200 |
| Nbr of stocks (in thousands) | 44,668 | 122,298 | 256,950 | 432,647 | 656,271 | 656,271 |
| Announcement Date | 4/14/21 | 4/15/22 | 9/1/23 | 5/16/24 | 4/10/25 | 3/31/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 1.55M | |
| 13.61x | 1.12x | 5.63x | - | 223M | |
| 11.15x | - | - | - | 144M | |
| 14.84x | - | - | - | 127M | |
| -1.19x | 0.66x | 2.9x | - | 95.4M | |
| -1.88x | 1.1x | 5.97x | - | 92.84M | |
| Average | 7.30x | 0.96x | 4.83x | 114M | ||
| Weighted average by Cap. | 9.14x | 1.01x | 5.07x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CPMD Stock
- Valuation CannaPharmaRX, Inc.
Select your edition
All financial news and data tailored to specific country editions
